United Therapeutics Corporation

Equities

UTHR

US91307C1027

Market Closed - Nasdaq Other stock markets 21:00:00 23/01/2026 GMT			5-day change	1st Jan Change
468.94 ^USD	-0.66%		+0.86%	-3.76%

01-22	United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to Board of Directors, Effective January 21, 2026	CI
01-15	United Therapeutics Insider Sold Shares Worth $3,900,122, According to a Recent SEC Filing	MT

Transcript : United Therapeutics Corporation Presents at UBS Global Healthcare Conference 2025, Nov-10-2025 09

Published on 11/10/2025 at 06:50 pm GMT - Modified on 01/16/2026 at 06:51 pm GMT

S&P Capital IQ

Presenter Speech
Ashwani Verma (Analysts)

Good day, everybody. Welcome to UBS Healthcare Conference. Next company on the podium here with me, United Therapeutics. And I'm really, really excited. We

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about United Therapeutics Corporation

01-22	United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to Board of Directors, Effective January 21, 2026	CI
01-15	United Therapeutics Insider Sold Shares Worth $3,900,122, According to a Recent SEC Filing	MT
01-12	United Therapeutics Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 01:30 PM
01-07	SAB Biotherapeutics, Inc. Announces Board Changes ,Effective January 7, 2026	CI
01-06	UBS Adjusts Price Target on United Therapeutics to $645 From $600, Maintains Buy Rating	MT
01-05	United Therapeutics Insider Sold Shares Worth $500,015, According to a Recent SEC Filing	MT
12-29	United Therapeutics Insider Sold Shares Worth $11,572,963, According to a Recent SEC Filing	MT
12-29	United Therapeutics Insider Sold Shares Worth $5,644,954, According to a Recent SEC Filing	MT
12-23	United Therapeutics Insider Sold Shares Worth $3,047,201, According to a Recent SEC Filing	MT
12-16	United Therapeutics Insider Sold Shares Worth $3,952,689, According to a Recent SEC Filing	MT
12-16	United Therapeutics Insider Sold Shares Worth $1,742,193, According to a Recent SEC Filing	MT
12-16	United Therapeutics Insider Sold Shares Worth $11,166,722, According to a Recent SEC Filing	MT
12-10	United Therapeutics Insider Sold Shares Worth $3,833,374, According to a Recent SEC Filing	MT
12-09	United Therapeutics Insider Sold Shares Worth $10,050,597, According to a Recent SEC Filing	MT
12-08	United Therapeutics Insider Sold Shares Worth $3,870,056, According to a Recent SEC Filing	MT
12-05	United Therapeutics Insider Sold Shares Worth $3,821,130, According to a Recent SEC Filing	MT
12-02	United Therapeutics Insider Sold Shares Worth $10,798,079, According to a Recent SEC Filing	MT
12-02	United Therapeutics Insider Sold Shares Worth $3,852,846, According to a Recent SEC Filing	MT
12-02	United Therapeutics Insider Sold Shares Worth $10,079,696, According to a Recent SEC Filing	MT
11-25	United Therapeutics Insider Sold Shares Worth $3,784,419, According to a Recent SEC Filing	MT
11-21	United Therapeutics Insider Sold Shares Worth $3,812,082, According to a Recent SEC Filing	MT
11-20	United Therapeutics Insider Sold Shares Worth $3,789,373, According to a Recent SEC Filing	MT
11-18	United Therapeutics Corporation Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 12:00 PM
11-14	United Therapeutics Insider Sold Shares Worth $4,755,854, According to a Recent SEC Filing	MT
11-13	United Therapeutics Insider Sold Shares Worth $5,112,335, According to a Recent SEC Filing	MT